HIIFS
EDIT icon

Harel Insurance Investments & Financial Services’s Editas Medicine EDIT Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,000
Closed -$902K – 770
2020
Q4 		$902K Buy
+4,000
New +$164K 0.02% 292

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harel Insurance Investments & Financial Services's EDIT Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 4,000 shares — an estimated $902K sold.

Harel Insurance Investments & Financial Services first reported a position in EDIT in Q4 2020 and held it in 1 quarter. The position peaked at $902K in Q4 2020. 313 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 4,000 Editas Medicine shares in Q1 2021, an estimated $902K.
  • Harel Insurance Investments & Financial Services first reported a position in Editas Medicine in Q4 2020 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Editas Medicine position peaked at $902K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.